Valuation

Wesfarmers' sale of Coregas for $770 million marks a strategic shift in asset management, impacting its valuation and future growth strategies on the ASX.

2024-12-20T03:19:50+0000

Viva Leisure embarks on global growth by bringing Plus Fitness to the UK, showcasing strategic expansion plans amid gym industry challenges.

2024-12-18T04:18:43+0000

The Canal+ IPO is on the horizon and most likely to be floated on the London Stock Exchange (LSE). Find out when it will take place, how you can buy and trade the company’s shares and learn more about its business model.

2024-12-12T17:23:54+0000

Integral Diagnostics strengthens its market position by acquiring Capital Health, approved by ASIC. The merger presents significant investment opportunities due to undervaluation.

2024-12-11T04:42:45+0000

Federal funding supports Iluka Resources' WA rare earths refinery under the Future Made in Australia program. Analysts weigh in on its impact amid weak demand for zircon and rutile.

2024-12-06T04:13:42+0000

Global equity markets show varying valuation levels in late 2024, with United States stocks trading at premium multiples while European markets trade at lower valuations.

2024-12-05T21:56:18+0000

Discover why Pro Medicus (ASX: PME) is captivating investors with a record-breaking $330 million contract, strong momentum, and analyst upgrades despite valuation concerns.

2024-12-05T03:10:47+0000

Analyse the valuation concerns of Australia's major banks, with insights on Commonwealth Bank's growth, sector warnings, and investment opportunities within the 'Big Four'.

2024-12-04T00:17:47+0000